Loading clinical trials...

Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle | Clinical Trials | Clareo Health

Active Not RecruitingNANCT06696118

Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle

The purpose of this study is to determine if Electromagnetic Transduction Therapy (EMTT) is a viable treatment option in patients with osteoarthritis of the foot and/or ankle.

Lead sponsor: Mayo Clinic•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhaseNA

Enrollment20

Start dateMar 2025

Last updatedMay 28, 2026

Condition

Osteoarthritis Ankle Osteoarthritis Foot

Locations shown

Mayo Clinic in Rochester

Rochester, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 28, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions